Nelson Teng

Publication Details

  • A modified technique for insertion of intraperitoneal port for chemotherapy.

    Liou WS, Teng NN, Chan JK. J Surg Oncol. 2005; 90 (4): 247-8

    The clinical and pharmacological rationale of using intraperitoneal (IP) chemotherapy has been demonstrated in randomized clinical trials. However, IP chemotherapy is often discontinued secondary to catheter-related complications such as blockage, leakage, infection, and access difficulties. An effective method that provides a reliable access to the IP cavity is needed. In this report, we describe a novel technique of IP port placement that may prevent access problems and decrease patient discomfort.

    PubMedID: 15906367

Stanford Medicine Resources:

Footer Links: